El CRAI romandrà tancat del 24 de desembre de 2025 al 6 de gener de 2026. La validació de documents es reprendrà a partir del 7 de gener de 2026.
El CRAI permanecerá cerrado del 24 de diciembre de 2025 al 6 de enero de 2026. La validación de documentos se reanudará a partir del 7 de enero de 2026.
From 2025-12-24 to 2026-01-06, the CRAI remain closed and the documents will be validated from 2026-01-07.
 
Miniatura

Fitxers

211082.pdf (555.96 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2018-08-29

Llicència de publicació

cc-by-nc (c) Trajanoska, K. et al., 2018
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/208901

Assessment of the genetic and clinical determinants of fracture risk: genome wide association and mendelian randomisation study

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1136/bmj.k3225

Resum

Objectives To identify the genetic determinants of fracture risk and assess the role of 15 clinical risk factors on osteoporotic fracture risk. Design Meta-analysis of genome wide association studies (GWAS) and a two-sample mendelian randomisation approach. Setting 25 cohorts from Europe, United States, east Asia, and Australia with genome wide genotyping and fracture data. Participants A discovery set of 37 857 fracture cases and 227 116 controls; with replication in up to 147 200 fracture cases and 150 085 controls. Fracture cases were defined as individuals (>18 years old) who had fractures at any skeletal site confirmed by medical, radiological, or questionnaire reports. Instrumental variable analyses were performed to estimate effects of 15 selected clinical risk factors for fracture in a two-sample mendelian randomisation framework, using the largest previously published GWAS meta-analysis of each risk factor. Results Of 15 fracture associated loci identified, all were also associated with bone mineral density and mapped to genes clustering in pathways known to be critical to bone biology (eg, SOST, WNT16, and ESR1) or novel pathways (FAM210A, GRB10, and ETS2). Mendelian randomisation analyses showed a clear effect of bone mineral density on fracture risk. One standard deviation decrease in genetically determined bone mineral density of the femoral neck was associated with a 55% increase in fracture risk (odds ratio 1.55 (95% confidence interval 1.48 to 1.63; P=1.5×10−68). Hand grip strength was inversely associated with fracture risk, but this result was not significant after multiple testing correction. The remaining clinical risk factors (including vitamin D levels) showed no evidence for an effect on fracture. Conclusions This large scale GWAS meta-analysis for fracture identified 15 genetic determinants of fracture, all of which also influenced bone mineral density. Among the clinical risk factors for fracture assessed, only bone mineral density showed a major causal effect on fracture. Genetic predisposition to lower levels of vitamin D and estimated calcium intake from dairy sources were not associated with fracture risk.

Matèries

Fractures, Factors de risc en les malalties, Osteoporosi, Genòmica

Matèries (anglès)

Fractures, Risk factors in diseases, Osteoporosis, Genomics

Citació

Col·leccions

Articles publicats en revistes (Genètica, Microbiologia i Estadística)

Citació

TRAJANOSKA, Katerina, MORRIS, John a., OEI, Ling, ZHENG, Hou-feng, EVANS, David m., KIEL, Douglas p., OHLSSON, Claes, RICHARDS, J. brent, RIVADENEIRA, Fernando, GEFOS/GENOMOS consortium, 23andMe Research Team, BALCELLS COMAS, Susana, GRINBERG VAISMAN, Daniel raúl. Assessment of the genetic and clinical determinants of fracture risk: genome wide association and mendelian randomisation study. _The BMJ - The British Medical Journal_. 2018. Vol. 362, núm. 1-14. [consulta: 7 de gener de 2026]. ISSN: 0959-8138. [Disponible a: https://hdl.handle.net/2445/208901]

Exportar metadades

JSON - METS

Compartir registre